Dr Reddys Laboratories (RDY) Cash & Current Investments (2012 - 2026)

Dr Reddys Laboratories' Cash & Current Investments history runs 15 years deep, the most recent figure standing at $169.8 million for Q1 2026.

• In Q1 2026, Cash & Current Investments fell 3.33% year-over-year to $169.8 million; the TTM figure through Mar 2026 stood at $169.8 million (down 3.33% YoY), while the FY2026 annual figure was $936.0 million, up 422.91% from the prior year.
• Cash & Current Investments was $169.8 million for Q1 2026 at Dr Reddys Laboratories, down from $199.8 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $751.8 million in Q1 2023 to a low of -$403.3 million in Q3 2022.
• Historically, Cash & Current Investments has averaged $144.9 million across 5 years, with a median of $140.1 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments slumped 287.03% in 2022, then soared 237.31% in 2023.
• A 5-year view of Cash & Current Investments shows it stood at -$403.3 million in 2022, then jumped by 119.53% to $78.8 million in 2023, then advanced by 13.81% to $89.6 million in 2024, then surged by 122.94% to $199.8 million in 2025, then declined by 15.02% to $169.8 million in 2026.
• The last three Cash & Current Investments figures came in at $169.8 million (Q1 2026), $199.8 million (Q3 2025), and $170.5 million (Q2 2025), per Business Quant data.